Health care leaders’ letter to the FDA: Concerns about approvals for rare disease therapeuticsNovember 21, 2025
Market Selloff on Renewed AI Bubble Fears; Lagarde Urges EU Reform | The Pulse 11/21November 21, 2025
Health care leaders’ letter to the FDA: Concerns about approvals for rare disease therapeuticsNovember 21, 2025
Market Selloff on Renewed AI Bubble Fears; Lagarde Urges EU Reform | The Pulse 11/21November 21, 2025
Share Facebook Twitter LinkedIn Pinterest Email Michael Lasser, UBS retail analyst, joins ‘Squawk Box’ to discuss how potential changes in tax and trade policy following the November presidential election could impact retailers, the impact of tariffs on consumers, and more.